Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from GSK

Kilwinning roadworks alert as 'frustrating' disruption set to last for one month

Roads to be dug up as a result of cabling work.

Daily Record

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

Investors Business Daily

Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market

Moderna stock surged early Wednesday after the company said its experimental RSV vaccine proved nearly 84% effective.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Must Have Pharma Stocks in January 2023

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

StockNews.com

GSK facing months of industrial action as workers go on strike at pharma giant

Electricians, scaffolders, cable pullers and labourers have downed tools in a dispute over bonus payments.

Daily Record

GSK to move back to central London with new HQ

Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO

Evening Standard

Moonpig flotation price, like so many, was always pie-in-the-sky thinking

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

FTSE 100 falls despite jump in healthcare stocks

The London Stock Exchange sank lower on Wednesday as energy and mining stocks dragged on the leading index.

Irish Independent

GSK shares surge as US judge dismisses Zantac cancer claims

About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer

The Guardian - UK

Morningstar Lists Undervalued Stocks with Strong Profits

As of Nov. 11, just 29% of Morningstar-covered stocks that reported Q3 earnings beat estimates by at least 10%.

The Street

EU watchdog backs Sanofi Covid booster jab

The Hague (AFP) - The EU on Thursday approved a Covid booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

AFP

Cheil India hires Kaushik Datta as executive creative director

He has worked across a wide swathe of industries and his repertoire of clients includes marquee brands like Hutch, Seagram, LG, Bacardi, Apple, Airtel, Kohler, Thums Up, Maaza, Limca, Minute Maid, Tinder, Fortis, Mc Donald’s, Popeyes, GM, SBI Card, GSK, Hindustan Times, Cargill and others.

Livemint

FTSE 100 drops despite eased restrictions in China as health firms dip

The FTSE dipped as it was impacted by weaker health stocks and caution over global political and economic uncertainty.

Irish Independent

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review

The stock market rally tumbled after Fed chief Powell signaled a higher peak rate. The jobs report and heavy earnings also swung stocks.

Investors Business Daily

Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth

Vir Biotechnology obliterated expectations for its Covid drug in the third quarter, and Vir stock leaped above its 200-day line.

The Guardian - UK

Mark Zuckerberg’s metaverse is a joke not shared by investors

Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course

Investors Business Daily

GSK Slips As Shingles Vaccine Drives Commanding Third-Quarter Beat

GSK stock jumped Wednesday after the company beat third-quarter forecasts due to strength from specialty medicines and Shingrix.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02

Reuters

Irish Independent

GSK raises annual outlook in strong start after consumer spin-off

Pharmaceutical giant GSK has increased its full-year earnings outlook once again following a better-than-expected third quarter performance thanks to surging global demand for its shingles vaccine.

The Independent UK

Strong RSV vaccine data lifts hopes after years of futility

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV

Wales Online

Gareth Thomas thanks ViiV for support in fight against HIV stigma

Gareth Thomas visited GSK House in his latest stop on the Myth Bus Tour.

The Guardian - UK

‘A better partner’: Labour woos big business in bid to oust Rishi Sunak

Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party prepares for election

StockNews.com

3 Upgraded Stocks to Consider Buying This Week

The red-hot inflation is increasing the odds of continued rate hikes by the Fed. Since the market is expected to remain under pressure on recession fears, it could be wise to invest in fundamentally sound stocks Comcast Corporation (CMCSA), GSK (GSK), and Masonite International (DOOR), which have been recently upgraded…

Evening Standard

GSK vaccine shows ‘exceptional’ efficacy against common lung infection RSV

The pharmaceutical giant’s vaccine was found to be 82.6 per cent effective in Phase III clinical trials

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations